Literature DB >> 25185212

Low-frequency versus high-frequency stimulation of the pedunculopontine nucleus area in Parkinson's disease: a randomised controlled trial.

D Nosko1, M U Ferraye2, V Fraix1, L Goetz1, S Chabardès1, P Pollak3, B Debû4.   

Abstract

OBJECTIVE: To compare the influence of low-frequency (10-25 Hz) versus higher (60-80 Hz) frequency stimulation of the pedunculopontine nucleus area (PPNa) on akinaesia, freezing of gait and daytime sleepiness.
METHOD: We included nine patients with Parkinson's disease (PD) and severe gait disorders. In this double-blind randomised cross-over study, patients were assessed after 24 h of PPNa stimulation. Assessments included the motor part of the Unified Parkinson's Disease Rating Scale, the Epworth Sleepiness Scale and a behavioural gait assessment.
RESULTS: Compared with 60-80 Hz, 10-25 Hz PPNa stimulation led to decreased akinaesia, gait difficulties and daytime sleepiness in 7/9 patients. In one patient, these symptoms were aggravated under 10-25 Hz stimulation compared with 60-80 Hz.
CONCLUSION: These results are in keeping with the benefits of chronic PPNa stimulation for gait and postural difficulties in patients with PD, and with regard to the influence of patients' clinical characteristics, differential neuronal loss in the PPNa and electrode location. We conclude that in patients with PPNa stimulation, low frequency provides a better outcome than high-frequency stimulation. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Gait; Movement Disorders; Neurosurgery; Parkinson's Disease

Mesh:

Year:  2014        PMID: 25185212     DOI: 10.1136/jnnp-2013-307511

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  8 in total

Review 1.  Axial disability and deep brain stimulation in patients with Parkinson disease.

Authors:  Alfonso Fasano; Camila C Aquino; Joachim K Krauss; Christopher R Honey; Bastiaan R Bloem
Journal:  Nat Rev Neurol       Date:  2015-01-13       Impact factor: 42.937

2.  A review of basal ganglia circuits and physiology: Application to deep brain stimulation.

Authors:  Robert S Eisinger; Stephanie Cernera; Aryn Gittis; Aysegul Gunduz; Michael S Okun
Journal:  Parkinsonism Relat Disord       Date:  2019-01-09       Impact factor: 4.891

Review 3.  Novel targets in deep brain stimulation for movement disorders.

Authors:  Alexander J Baumgartner; John A Thompson; Drew S Kern; Steven G Ojemann
Journal:  Neurosurg Rev       Date:  2022-05-05       Impact factor: 2.800

Review 4.  Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality?

Authors:  Thomas Wichmann; Mahlon R DeLong
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

Review 5.  Pedunculopontine Nucleus Deep Brain Stimulation Improves Gait Disorder in Parkinson's Disease: A Systematic Review and Meta-analysis.

Authors:  Fabin Lin; Dihang Wu; Chenxin Lin; Huihui Cai; Lina Chen; Guofa Cai; Qinyong Ye; Guoen Cai
Journal:  Neurochem Res       Date:  2020-01-16       Impact factor: 3.996

6.  LFP Oscillations in the Mesencephalic Locomotor Region during Voluntary Locomotion.

Authors:  Brian R Noga; Francisco J Sanchez; Luz M Villamil; Christopher O'Toole; Stefan Kasicki; Maciej Olszewski; Anna M Cabaj; Henryk Majczyński; Urszula Sławińska; Larry M Jordan
Journal:  Front Neural Circuits       Date:  2017-05-19       Impact factor: 3.492

Review 7.  Dopamine and the Brainstem Locomotor Networks: From Lamprey to Human.

Authors:  Dimitri Ryczko; Réjean Dubuc
Journal:  Front Neurosci       Date:  2017-05-26       Impact factor: 4.677

8.  Frequency-dependent effects of subthalamic deep brain stimulation on motor symptoms in Parkinson's disease: a meta-analysis of controlled trials.

Authors:  Dongning Su; Huimin Chen; Wanli Hu; Yuye Liu; Zhan Wang; Xuemei Wang; Genliang Liu; Huizi Ma; Junhong Zhou; Tao Feng
Journal:  Sci Rep       Date:  2018-09-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.